TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: initial postoperative lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from children's weight (z-BMI score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from levels of anxiety symptomatology in children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from levels of depressive symptomatology in children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone width gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Composite of Stroke, Systemic Embolism, and Death
Endpoint domain: Mortality/survival
Primary endpoint: Composite of Ischemic Stroke or Systemic Embolism
Endpoint domain: Mortality/survival
Primary endpoint: Modified Borg scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 min sit to stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uvula edema reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from the Mini-Mental State Examination scale (MMSE) at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from the clinical efficacy at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of needed vasopressor (phenylephrine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Tools Required to Retract the Prostate During Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Device Related Adverse Events (Safety)
Endpoint domain: Adverse events/effects
Primary endpoint: rate of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: re-hospitalization due to right heart failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of Hyperammonemic Crisis (HAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in Partial Seizure Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life EQ-5D-5L score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with neuro activity to facial expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: New/relapsing opportunistic infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Grade 4 clinical endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perceived benefits towards active transport
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perceived barriers towards active transport
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in intention to use active transport after obtaining a driving license
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Usage rate of the Medical Companion application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stent failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Need for re-procedure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in clotting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants With Any Severity of Rotavirus Gastroenteritis
Endpoint domain: Adverse events/effects
Primary endpoint: Time in deep sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: rate of transplant rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Time in Range of 70 to 180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of clinical pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiotensin levels (pg/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum levels of S100B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Groton Maze Learning Test (Total Errors)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude towards disability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Muscle strength testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscular endurance and neuromuscular tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity of FujiLAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of FujiLAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of FujiLAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients free from atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants developing viremia
Endpoint domain: Adverse events/effects
Primary endpoint: Frailty trend
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's treatment recommendations
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cognitive function evaluation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Glycated Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete Response Rate (CRR)
Endpoint domain: Mortality/survival
Primary endpoint: All-Cause Death
Endpoint domain: Mortality/survival
Primary endpoint: Cardiopulmonary Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in wound surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of false positive cases in lung cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Insula activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of target reached within 8 mm radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montgomery-Asberg Depression Rating Scale (MADRS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Montgomery-Asberg Depression Rating Scale (MADRS) augmentation of >5 points or clinical worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of (Serious) Adverse Events related to Investigational Medical Device and / or surgical procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Range of passive movement of the wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Range of active movement of the wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Volume of the uterine leiomyomata
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Influenza infection
Endpoint domain: Adverse events/effects
Primary endpoint: safety and efficacy of transgastric NOTES procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change From Baseline in ACR-N AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in capsular contructure incidence
Endpoint domain: Adverse events/effects
Primary endpoint: glutamate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects completing follow-up and cMR imaging
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in the frequency spectrum after training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Audiogram results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled Sodium (mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net Exhaled Chloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clinical Disease Activity Score (DAS) remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good responder proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of insulin-independence at 6 and 12 months after transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of insulin-independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acute Stimulated Tear Production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Experienced One or More Device-related Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Patients Completing Bioenergetics Profiling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline of FMA-UE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of participants retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of days participants practiced Tai-chi at home
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: cerebro-splanchnic oxygenation ratio (CSOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Intensity Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved skin barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in Morning Peak Expiratory Flow (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in uptake of [18F]-ML-10 by target lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking abilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clotting Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: GVHD-free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Participants With Grade 3 or Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Initial participation rate of cancer survivors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of survivors' self-generated survivorship care plans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of survivors who receive the phone-based education session
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of survivors who complete the follow-up questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response rate among primary care providers to the PCP survey
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of subjects with at least 70% of the hair extensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of late enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1 minute sit to stand test (STS) repetitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 minute step test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of Intraocular Pressure (IOP) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of image artefacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast induced nephropathy (CIN) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: performance on quality indicators at patient level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: performance on quality indicators at hospital level
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Immunosuppression adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the MDS-UPDRS Tremor Subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time required for uterine closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total psoas muscle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time of Maximum Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC0-72)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knee Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knee Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to short-term antibiotic
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Patients Successfully Withdrawn From Oral Immunosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durable platelet response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants achieving platelet counts at or above 50,000/μL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of blood oxygenation (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall Preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference of Taste
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference of Consistency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference of Portability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Quantitative Myasthenia Gravis (QMG) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cerebral desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Magnitude of cerebral desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative day of discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of Participants With 30% Decline in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in OCD symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Primary Graft Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrodermal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiration Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of complications after childhood cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea/vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall feeling of well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Validity of Dexcom G6 CGM system measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral oxygenation parameter change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for Criminal Recidivism
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Salivary Alpha-Amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Apolipoprotein B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Small LDL concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Large LDL particle concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Total LDL particle concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in antiretroviral adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in engagement in HIV-related Care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of quadriceps muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average Interfraction Shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Residual Error Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durometer Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Over the Curve (AOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction to normal cytology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Who Achieved Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time of capillary glucose levels spent between 4-10 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute and long-term toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of ischemic heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of significant epicardial stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Maximum Change in Hb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to Prostate-Specific Antigen Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful intrauterine device insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postprandial Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Preoperative anxiety measurement (STAI-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preoperative anxiety measurement (STAI-T)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative pain measurement (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infants with HBV infection at 28 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants and paired infants with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Quantity of oral nitrate reducing bacterial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral bacterial nitrate reductase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference between groups in nitrate/nitrite concentrations before and after dietary nitrate dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) determined by dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Composite Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with acute respiratory infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Change in Pain Intensity Per Hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of side effects of chemotherapy for WHO grade greater than 2
Endpoint domain: Adverse events/effects